Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benign osteoblastoma of maxilla: a case report emphasizing the histopathological differential diagnosis.

Journal of clinical and diagnostic research : JCDR·2014
Same author

Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.

Bioorganic & medicinal chemistry letters·2014
Same author

Coordination mode of pentadentate ligand derivative of 5-amino-1,3,4-thiadiazole-2-thiol with nickel(II) and copper(II) metal ions: synthesis, spectroscopic characterization, molecular modeling and fungicidal study.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2014
Same author

Epigenetic regulation of human cytomegalovirus latency: an update.

Epigenomics·2014
Same author

Differential temporal expression of milk miRNA during the lactation cycle of the marsupial tammar wallaby (Macropus eugenii).

BMC genomics·2014
Same author

Association between Functional Severity and Amputation Type with Rehabilitation Outcomes in Patients with Lower Limb Amputation.

Rehabilitation research and practice·2014

Related Experiment Video

Updated: May 12, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.

Eleonora Cocco1, Raffaele Murru, Gianna Costa

  • 1Multiple Sclerosis Center, Department of Public Health and Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy.

Plos One
|April 18, 2013
PubMed
Summary

This study investigated human leukocyte antigen (HLA)-DRB1-DQB1 gene variants in Sardinian multiple sclerosis (MS) patients. Specific gene variants were identified that increase susceptibility or provide protection against developing MS.

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Related Experiment Videos

Last Updated: May 12, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Human Genetics

Background:

  • Multiple sclerosis (MS) is a complex autoimmune disease with a significant genetic component.
  • Human leukocyte antigen (HLA) genes, particularly HLA-DRB1 and HLA-DQB1, are strongly associated with MS susceptibility.
  • Understanding specific HLA haplotypes and their interactions is crucial for elucidating MS pathogenesis.

Purpose of the Study:

  • To analyze the interaction between HLA-DRB1-DQB1 haplotypes and their association with multiple sclerosis (MS) risk in the Sardinian population.
  • To identify specific genotypes conferring susceptibility or protection against MS.
  • To explore the functional implications of these genetic associations on antigen presentation.

Main Methods:

  • A case-control study involving 2,555 Sardinian MS patients and 1,365 healthy controls.
  • Analysis of HLA-DRB1-DQB1 haplotypes and their genotypic interactions.
  • Phylogenetic tree construction, sequence alignment, and molecular dynamics simulations.

Main Results:

  • Four HLA-DRB1-DQB1 haplotypes (*13:03-*03:01, *04:05-*03:01, *15:01-*06:02, *03:01-*02:01) were found to confer susceptibility to MS.
  • Several haplotypes (*11, *16:01-*05:02, *14:01-4-*05:031, *15:02-*06:01) showed a protective effect.
  • Relative predispositional effect analysis confirmed susceptibility for *08 and *04 haplotypes.
  • Interactions between haplotypes were classified as neutral or negative.
  • Sequence analysis identified key amino acid positions (near P4 and P9 pockets) and molecular dynamics pinpointed position 70 in relation to MBP 85-99 peptide binding.

Conclusions:

  • Specific HLA-DRB1-DQB1 haplotypes significantly influence MS risk in the Sardinian population.
  • The identified genetic variations may affect antigen presentation mechanisms, contributing to MS susceptibility.
  • Functional analysis of specific amino acid positions provides insights into the molecular basis of MS pathogenesis related to HLA alleles.